Should we consider pars plana vitrectomy in the primary treatment of diabetic macular edema?

Should we consider pars plana vitrectomy in the primary treatment of diabetic macular edema?

Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for DME is anti-VEGF treatment. Even though recent clinical trials have shown that anti-VEGF treatment is superior to laser photocoagulation there are certain concerns...

Full description

Bibliographic Details
Main Authors: Lihteh Wu, Evelyn Yeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:The Pan-American Journal of Ophthalmology
Subjects:
diabetic macular edema; vegf; pars plana vitrectomy; oxygen; ranibizumab; bevacizumab; aflibercept; laser photocoagulation; vitreomacular traction; diabetic retinopathy
Online Access:http://www.thepajo.org/article.asp?issn=2666-4909;year=2017;volume=16;issue=1;spage=12;epage=14;aulast=Wu;type=0

Internet

http://www.thepajo.org/article.asp?issn=2666-4909;year=2017;volume=16;issue=1;spage=12;epage=14;aulast=Wu;type=0

Similar Items